Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

uniQure

NASDAQ QURE
$5.06 0.15 2.96%
Today share price
Netherlands
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

244.83M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
113.56M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.13
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
48.38M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-25.26 %

Upcoming events uniQure

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart uniQure

Stock analysis uniQure

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.82 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
1.18 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.45 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.52 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-202.29 7.67

Price change uniQure per year

25.80$ 52.19$
Min Max

Summary analysis uniQure

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure uniQure

Revenue and net income uniQure

All parameters

Stock news uniQure

All news
5 October 2023 в 15:25

UniQure to cut 28% of workforce and scrap more than half its research projects in strategic overhaul

5 October 2023 в 14:30

UniQure to Cut Costs, Lay Off Staff And Close Lab

5 October 2023 в 14:30

UniQure to Cut Costs, Lay Off Staff And Close Lab

5 September 2023 в 20:35

Re/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit From S&P SmallCap 600

5 September 2023 в 20:35

Re/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit From S&P SmallCap 600

21 June 2023 в 17:15

UniQure Shares Sink 42% After Huntington's Study Update

21 June 2023 в 17:15

UniQure Shares Sink 42% After Huntington's Study Update

15 May 2023 в 14:46

uniQure to Sell Royalty Interest in Hemgenix for Up To $400 Million

15 May 2023 в 14:46

uniQure to Sell Royalty Interest in Hemgenix for Up To $400 Million

23 November 2022 в 21:50

Shares of uniQure Rise Almost 12% After FDA Approves Hemgenix

23 November 2022 в 21:50

Shares of uniQure Rise Almost 12% After FDA Approves Hemgenix

23 November 2022 в 15:35

UniQure stock price target raised to $65 from $51 at Truist

8 August 2022 в 18:15

UniQure Shares Slide as Part of Huntington's Study Delayed >QURE

8 August 2022 в 18:10

UniQure Shares Slide as Part of Huntington's Study Delayed >QURE

12 July 2022 в 12:50

Up 43% In A Month, Will UniQure Stock See Further Gains?

23 June 2022 в 17:16

UniQure Shares Rise 15% After Positive News for AMT-130 Huntington's Treatment

23 June 2022 в 17:16

UniQure Shares Rise 15% After Positive News for AMT-130 Huntington's Treatment

16 December 2021 в 18:20

UniQure Shares Drop 18% After Data for Huntington's Disease Treatment

16 December 2021 в 18:20

UniQure Shares Drop 18% After Data for Huntington's Disease Treatment

4 November 2021 в 16:20

What’s Next For UniQure Stock After A 10% Rise In A Month?

About company uniQure

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-180 for the treatment of hemophilia A; AMT-190, an IV-administered adeno-associated virus (AAV) 5-based gene therapy for the treatment of Fabry disease; and AMT-150, a one-time, intrathecally-administered, AAV gene therapy for treating spinocerebellar ataxia type 3. The company has collaboration and license agreements with Bristol Myers-Squibb Company; Gen-X; and Synpromics Limited. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Address:
Paasheuvelweg 25a, Amsterdam, Netherlands, 1105 BP
Company name: uniQure
Issuer ticker: QURE
ISIN: NL0010696654
Country: Netherlands
Exchange: NASDAQ
Currency: $
IPO date: 2007-06-20
Sector: Healthcare
Industry: Biotechnology
Site: https://www.uniqure.com

On which stock exchange are uniQure (QURE) stocks traded?

uniQure (QURE) stocks are traded on NASDAQ.

What is the ticker of uniQure stocks (QURE)?

The stock ticker of uniQure’s stocks or in other words, the code is QURE. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does uniQure (QURE) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, uniQure (QURE) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are uniQure (QURE) stocks traded?

uniQure (QURE) stocks are traded on the NASDAQ exchange in dollars.

What is the price of uniQure (QURE) stocks today?

The current price of uniQure stocks on 16.05.2024 is 5.06 dollars. per share.

What is the dynamics of uniQure (QURE) stocks from the beginning of the year?

uniQure (QURE) quotes have increased by -26.98% from the beginning of the year up to 5.06 dollars. per 1 stocks.

How much did uniQure (QURE) stocks increase in мае 2024?

This month uniQure (QURE) quotes have increased by 10.72% to 5.06 dollars. per share.

How much are uniQure (QURE) stocks worth?

Today, on October, 16.05.2024 uniQure’s (QURE) stocks cost 5.06 dollars..

What is the market capitalization of uniQure (QURE)?

Capitalization is the market value of uniQure (QURE) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of uniQure (QURE) is estimated at about 244825621 dollars.